Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

34 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
High levels of resistance to nucleoside/nucleotide reverse transcriptase inhibitors in newly diagnosed antiretroviral treatment-naive children in sub-Saharan Africa.
Inzaule SC, Jordan MR, Bello G, Wadonda-Kabondo N, Mounerou S, Mbulli IA, Akanmu SA, Vubil A, Hunt G, Kaleebu P, Mthethwa-Hleza S, Dzangare J, Njukeng P, Penazzato M, Rinke de Wit TF, Eshleman SH, Bertagnolio S; Infant HIV Drug Resistance Survey Team. Inzaule SC, et al. AIDS. 2020 Aug 1;34(10):1567-1570. doi: 10.1097/QAD.0000000000002580. AIDS. 2020. PMID: 32443062
A retrospective survey of HIV drug resistance among patients 1 year after initiation of antiretroviral therapy at 4 clinics in Malawi.
Wadonda-Kabondo N, Hedt BL, van Oosterhout JJ, Moyo K, Limbambala E, Bello G, Chilima B, Schouten E, Harries A, Massaquoi M, Porter C, Weigel R, Hosseinipour M, Aberle-Grasse J, Jordan MR, Kabuluzi S, Bennett DE. Wadonda-Kabondo N, et al. Clin Infect Dis. 2012 May;54 Suppl 4(Suppl 4):S355-61. doi: 10.1093/cid/cis004. Clin Infect Dis. 2012. PMID: 22544203 Free PMC article.
Prevalence of HIV drug resistance before and 1 year after treatment initiation in 4 sites in the Malawi antiretroviral treatment program.
Wadonda-Kabondo N, Bennett D, van Oosterhout JJ, Moyo K, Hosseinipour M, Devos J, Zhou Z, Aberle-Grasse J, Warne TR, Mtika C, Chilima B, Banda R, Pasulani O, Porter C, Phiri S, Jahn A, Kamwendo D, Jordan MR, Kabuluzi S, Chimbwandira F, Kagoli M, Matatiyo B, Demby A, Yang C. Wadonda-Kabondo N, et al. Clin Infect Dis. 2012 May;54 Suppl 4(Suppl 4):S362-8. doi: 10.1093/cid/cir987. Clin Infect Dis. 2012. PMID: 22544204 Free PMC article.
Resistance levels to non-nucleoside reverse transcriptase inhibitors among pregnant women with recent HIV infection in Malawi.
Bello G, Kagoli M, Chipeta S, Auld A, Chang JC, DeVos JR, Kim E, Mkungudza J, Payne D, Eliya M, Nyirenda R, Jahn A, Mzumara T, Mvula B, Dadabhai S, Namakhoma I, Babaye Y, Giron A, Jordan MR, Bertagnolio S, O'Malley G, Wadonda-Kabondo N. Bello G, et al. Among authors: wadonda kabondo n. Antivir Ther. 2022 Aug;27(4):13596535221121225. doi: 10.1177/13596535221121225. Antivir Ther. 2022. PMID: 35976773 Free PMC article.
Early warning indicators for HIV drug resistance in Malawi.
Hedt BL, Wadonda-Kabondo N, Makombe S, Harries AD, Schouten EJ, Limbambala E, Hochgesang M, Aberle-Grosse J, Kamoto K. Hedt BL, et al. Antivir Ther. 2008;13 Suppl 2:69-75. Antivir Ther. 2008. PMID: 18575193
Simultaneous detection of major drug resistance mutations in the protease and reverse transcriptase genes for HIV-1 subtype C by use of a multiplex allele-specific assay.
Zhang G, Cai F, Zhou Z, DeVos J, Wagar N, Diallo K, Zulu I, Wadonda-Kabondo N, Stringer JS, Weidle PJ, Ndongmo CB, Sikazwe I, Sarr A, Kagoli M, Nkengasong J, Gao F, Yang C. Zhang G, et al. J Clin Microbiol. 2013 Nov;51(11):3666-74. doi: 10.1128/JCM.01669-13. Epub 2013 Aug 28. J Clin Microbiol. 2013. PMID: 23985909 Free PMC article.
34 results